Question: Please describe this drug.
 The Compound has the SMILES CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O.
Result: Fospropofol is a water soluble prodrug and is converted to propofol in the liver. Fospropofol is a short acting hypnotic/sedative/anesthetic agent. Unlike propofol, does not cause injection-site pain as it is unable to activate TRPA1. FDA approved in December 2008. Fospropofol is a Schedule IV controlled substance in the United States under the Controlled Substances Act.
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O
CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)(O)O
[2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate
Please describe this drug.
Fospropofol is a water soluble prodrug and is converted to propofol in the liver. Fospropofol is a short acting hypnotic/sedative/anesthetic agent. Unlike propofol, does not cause injection-site pain as it is unable to activate TRPA1. FDA approved in December 2008. Fospropofol is a Schedule IV controlled substance in the United States under the Controlled Substances Act.